Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Kidney cysteine conjugate beta-lyase (kyneurenine aminotranferase 1) metabolizes the cysteine conjugates of certain halogenated alkenes and alkanes to form reactive metabolites that can produce nephrotoxicity and neurotoxicity. KAT1 also catalyses the reversible transamination of glutamine to oxoglutaramic acid and converts kynurenine into kynurenic acid (KYNA), a broadspectrum antagonist at ionotropic excitatory amino acid receptors. It exists in a cytosolic and a mitochondrial form due to the presence of KAT1 mRNAs coding for proteins with and without leader sequences.
Gene Name: | cysteine conjugate-beta lyase, cytoplasmic |
Synonyms: | CCBL1, Beta-lysase, kidney, KAT1, KATI, Kynurenine aminotransferase I, Kyneurenine aminotransferase, Kynurenic acid transferase 1, GTK, Glutamine transaminase K |
Target Sequences: | NM_004059 NP_004050.3 Q16773 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.